MP36-02 A COMPARISION OF THE AORTIC-LESION-ATTENUATION-DIFFERENCE (ALAD) AND PEAK EARLY-PHASE ENHANCEMENT RATIO (PEER) TO PREOPERATIVELY DIFFERENTIATE BENIGN FROM MALIGNANT RENAL MASSES | Zendy

AI Assistant Blog Pricing

MP36-02 A COMPARISION OF THE AORTIC-LESION-ATTENUATION-DIFFERENCE (ALAD) AND PEAK EARLY-PHASE ENHANCEMENT RATIO (PEER) TO PREOPERATIVELY DIFFERENTIATE BENIGN FROM MALIGNANT RENAL MASSES

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.